Provided by Tiger Trade Technology Pte. Ltd.

ENDRA Life Sciences Inc

5.01
-0.4000-7.40%
Volume:24.53K
Turnover:133.32K
Market Cap:7.51M
PE:-0.80
High:5.77
Open:5.59
Low:5.01
Close:5.41
52wk High:9.85
52wk Low:2.96
Shares:1.50M
Float Shares:1.43M
Volume Ratio:1.76
T/O Rate:1.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.2900
EPS(LYR):-8.9291
ROE:-152.04%
ROA:-77.32%
PB:1.19
PE(LYR):-0.56

Loading ...

ENDRA Life Sciences Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Jun 01

ENDRA Life Sciences prices $3.8 million private placement at $6.57 per share with warrants

Reuters
·
May 28

ENDRA Life Sciences Q1 EPS $(1.09) Beats $(1.14) Estimate

Benzinga Earnings
·
May 18

ENDRA Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
May 18

ENDRA Life Sciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 16

ENDRA net loss widens 26.55% to $1.31 million in Q1 FY26

Reuters
·
May 16

Endra Life Sciences reports multi-site validation of TAEUS Liver device

TIPRANKS
·
May 15

ENDRA Life Sciences Inc trading resumes

TIPRANKS
·
May 14

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:38 PM

Reuters
·
May 14

ENDRA Life Sciences Inc expected to post a loss of $1.23 a share - Earnings Preview

Reuters
·
May 11

ENDRA risks Nasdaq delisting after falling below $2.5 million equity requirement

Reuters
·
Apr 21

ENDRA Life Sciences Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Apr 01

ENDRA Life Sciences Q4 EPS $(3.25) Misses $(1.95) Estimate

Benzinga Earnings
·
Apr 01

ENDRA Life Sciences Q4 net loss narrows

Reuters
·
Apr 01

ENDRA FY25 net loss narrows to $7 million; operating expenses fall to $5.8 million

Reuters
·
Apr 01

Press Release: ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Dow Jones
·
Apr 01

ENDRA Life Sciences Inc expected to post a loss of $1.23 a share - Earnings Preview

Reuters
·
Mar 27

ENDRA Life Sciences Inc - on March 19 ,Reduced Number of Employees in Order to Reduce Cash Expenditures and Extend Its Operational Runway- SEC Filing

THOMSON REUTERS
·
Mar 25

BRIEF-Endra Life Sciences Initiates Review Of Strategic Alternatives To Maximize Shareholder Value

Reuters
·
Mar 25

ENDRA Life Sciences initiates review of strategic alternatives; board evaluates options including investments, mergers, and asset sales

Reuters
·
Mar 25